These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2468618)

  • 1. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
    Schmutzler W; Neukirch B; Ziesche R
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the inhibition of histamine release by inosine pranobex.
    Ziesche R; Eichelberg D; Schmutzler W
    Agents Actions; 1987 Apr; 20(3-4):172-3. PubMed ID: 2440263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of isoprinosine treatment on histamine release from murine peritoneal mast cells.
    Brzezińska-Błaszczyk E; Karczewska M; Ubysz-Jerzmanowska K
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):103-5. PubMed ID: 1284365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
    De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
    Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice.
    Renoux G; Renoux M; Degenne D
    Int J Immunopharmacol; 1979; 1(3):239-41. PubMed ID: 95251
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
    Kovacs JA; Powell F; Voeller D; Allegra CJ
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
    Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
    J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of isoprinosine on rabies virus.
    Hernández-Jáuregui P; González-Vega D; Cruz-Lavín E; Hernández-Baumgarten E
    Am J Vet Res; 1980 Sep; 41(9):1475-8. PubMed ID: 6160794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of OK-432, inosine pranobex and its salt components on macrophage subpopulations in spleen and peritoneum of mice during the primary humoral immune response.
    Zwadlo-Klarwasser G; Drube S; Schmutzler W
    J Investig Allergol Clin Immunol; 1992; 2(2):73-7. PubMed ID: 1285273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro antiviral activity of isoprinosine on simian rotavirus (SA-11).
    Linhares RE; Wigg MD; Lagrota MH; Nozawa CM
    Braz J Med Biol Res; 1989; 22(9):1095-103. PubMed ID: 2483980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
    Glasky AJ; Gordon JF
    Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.
    Hadden JW; Hadden EM; Coffey RG
    Infect Immun; 1976 Feb; 13(2):382-7. PubMed ID: 57100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of 6-ethyl-3-(1H-tetrazol-5-YL)chromone (AA-344) on IgE, IgGa- or chemical agent-induced histamine release from isolated rat mast cells.
    Saijo T; Ashida Y; Kuriki H; Kanno M; Maki Y
    Jpn J Pharmacol; 1979 Aug; 29(4):531-40. PubMed ID: 94114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inosiplex, a stimulating agent for normal human T cells and human leukocytes.
    Wybran J; Govaerts A; Appelboom T
    J Immunol; 1978 Sep; 121(3):1184-7. PubMed ID: 80429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic immunoenhancement in the elderly: in vitro effects of isoprinosine.
    Delafuente JC; Panush RS
    Clin Immunol Immunopathol; 1988 Jun; 47(3):363-7. PubMed ID: 2453315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.